SCHEMBL898309

SCHEMBL898309

O=S(=O)(O)c1c(O)c(O)c2ccccc2c1S(=O)(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.46
PADI4 Q9UM07 1/20 0.42
MPL P40238 2/20 0.40
CYP1A2 P05177 1/20 0.40
DAPK1 P53355 1/20 0.40
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSP90AA1 P07900 1/20 0.38
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPT P10636 3/20 0.36
HSD17B10 Q99714 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
PKM P14618 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
CYP2C9 P11712 1/20 0.36
MCL1 Q07820 1/20 0.36
CTRB1 P17538 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28517657 0.91 CYP2D6 (0.50) CYP2D6PADI4MPLCYP1A2DAPK1
SCHEMBL358739 0.91 CYP2D6 (0.46) CYP2D6PADI4MPLCYP1A2DAPK1
SCHEMBL15522435 0.89 CYP2D6 (0.47) CYP2D6PADI4MPLCYP1A2DAPK1
SCHEMBL7543033 0.89 CYP2D6 (0.51) CYP2D6PADI4MPLCYP1A2DAPK1
SCHEMBL2524546 0.84 TSHR (0.48) CYP2D6PADI4MPLCYP1A2DAPK1
SCHEMBL9548576 0.83 CYP2D6 (0.50) CYP2D6PADI4MPLCYP1A2DAPK1
SCHEMBL8915189 0.82 DAPK1 (0.51) CYP2D6PADI4CYP1A2DAPK1TSHR
SCHEMBL8379569 0.82 DAPK1 (0.47) CYP2D6PADI4MPLCYP1A2DAPK1
Hydrochloric Acid SCHEMBL11755878 0.81 TSHR (0.46) CYP2D6PADI4MPLCYP1A2DAPK1
SCHEMBL14879315 0.81 TSHR (0.50) CYP2D6PADI4MPLCYP1A2DAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020142700-A1 BINDING DOMAIN MAPPING AND COMPOUNDS, COMPOSITIONS, COMPLEXES, METHODS, AND KITS RELATED THERETO George Mason Research Foundation, Inc. (US) 2020-07-09 WO claimed
EP-0485474-A1 A METHOD AND A SYSTEM FOR QUANTITATIVELY MONITORING A CHEMICAL COMPONENT DISSOLVED IN A LIQUID MEDIUM. KOEGE KEMISK VAERK (DK) 1992-05-20 EP claimed
WO-1991002254-A1 A METHOD AND A SYSTEM FOR QUANTITATIVELY MONITORING A CHEMICAL COMPONENT DISSOLVED IN A LIQUID MEDIUM KEMISK VÆRK KØGE A/S (DK) 1991-02-21 WO claimed
EP-0122523-A2 Diazotype compositions and materials Andrews Paper and Chemical Co., Inc. (US) 1984-10-24 EP claimed
US-4045428-A Water-soluble reactive naphthylazonaphthyl dyestuffs HOECHST AKTIENGESELLSCHAFT (DT) 1977-08-30 US claimed
US-20250333472-A1 Binding Domain Mapping and Compounds, Compositions, Complexes, Methods, and Kits Related Thereto GEORGE MASON RES FOUNDATION INC (US) 2025-10-30 US disclosed
US-12331096-B2 Binding domain mapping and compounds, compositions, complexes, methods, and kits related thereto George Mason Research Foundation, Inc. (US) 2025-06-17 US disclosed
EP-3375826-B1 COMPOSITION AND METHOD FOR FORMING ELECTROACTIVE POLYMER SOLUTION OR COATING COMPRISING CONJUGATED HETEROAROMATIC POLYMER, ELECTROACTIVE POLYMER SOLUTION, OBJECTS COMPRISING THE ELECTROACTIVE COATING, AND SOLID ELECTROLYTIC CAPACITOR AND METHOD FOR FABRICATING THE SAME POLYM TECH CORPORATION (TW) 2023-12-27 EP disclosed
US-11655378-B2 Electroactive polymer solution comprising conjugated heteroaromatic polymer, electroactive coating comprising the same, and objects comprising electroactive coating POLYM TECHNOLOGY CORPORATION (TW) 2023-05-23 US disclosed
US-11600449-B2 Layer compositions with improved electrical parameters comprising PEDOT/PSS and a stabilizer HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) 2023-03-07 US disclosed
EP-3419033-B1 A SOLID POLYMER CAPACITOR HAVING IMPROVED ELECTRICAL PARAMETERS AT LOW TEMPERATURE HERAEUS DEUTSCHLAND GMBH & CO KG (DE) 2023-02-01 EP disclosed
WO-2020142700-A1 BINDING DOMAIN MAPPING AND COMPOUNDS, COMPOSITIONS, COMPLEXES, METHODS, AND KITS RELATED THERETO George Mason Research Foundation, Inc. (US) 2020-07-09 WO disclosed
EP-0131824-B1 PHOTOPOLYMERIZABLE COMPOSITION FUJI PHOTO FILM CO., LTD. (JP) 1990-05-09 EP disclosed
US-4572888-A DRY FILM PHOTO RESISTS INCORPORATING A CARBOTHIO ACID AMIDE OR A THIO=HYDRAZIDE FUJI PHOTO FILM CO., LTD. (JP) 1986-02-25 US disclosed
US-4543318-A PHOTORESISTS FOR CIRCUIT BOARDS AND PRINTING PLATES FUJI PHOTO FILM CO., LTD. (JP) 1985-09-24 US disclosed
EP-0131824-A2 Photopolymerizable composition FUJI PHOTO FILM CO., LTD. (JP) 1985-01-23 EP disclosed
US-4304838-A FILMS FOR PEELABLE DEVELOPMENT FUJI PHOTO FILM CO., LTD. (JP) 1981-12-08 US disclosed
US-4175964-A SUCCESSIVE SURFACE TREATMENT WITH AQUEOUS SOLUTIONS OF PHOSPHORIC ACID AND SILICIC ACID OR ITS SALTS FUJI PHOTO FILM CO., LTD. (JP) 1979-11-27 US disclosed
US-4163675-A CONTAINING NAPHTHALENE DERIVATIVES PILOT INK CO., LTD. (JP) 1979-08-07 US disclosed
US-4050936-A Image forming process with photopolymer layers between a support and a substrate FUJI PHOTO FILM CO., LTD. (JA) 1977-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250333472-A1 Binding Domain Mapping and Compounds, Compositions, Complexes, Methods, and Kits Related Thereto SNRPE, SSBP1, RPA1 CYP2D6 4476/4885PADI4 4414/4885MPL 4768/4885
US-12331096-B2 Binding domain mapping and compounds, compositions, complexes, methods, and kits related thereto SNRPE, SSBP1, RPA1 CYP2D6 4476/4885PADI4 4414/4885MPL 4768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.